A Novel hTERT Promoter-driven E1A Therapeutic for Ovarian Cancer

Currently, an effective gene therapy strategy, which not only retains cancer-specific expression but also limits toxicity, has yet to be developed for ovarian cancer. Mounting reports over the years have shown that human telomerase activity is significantly elevated in cancer cells compared with nor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Xie, Xiaoming, Hsu, Jennifer L., Choi, Min-Gew, Xia, Weiya, Yamaguchi, Hirohito, Chen, Chun-Te, Trinh, Bon Q., Lu, Zhen, Ueno, Naoto T., Wolf, Judith K., Bast, Robert C., Hung, Mien-Chie
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2759534/
https://ncbi.nlm.nih.gov/pubmed/19671744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-09-0056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados